Emerging Trade Pacts Offer Opportunities In Face Of DRG Payment Woes – Ubl
This article was originally published in The Gray Sheet
Executive Summary
Central America and some Asian countries provide emerging overseas growth areas for device manufacturers, according to AdvaMed Exec VP-Federal Government Relations Steve Ubl
You may also be interested in...
Japanese Price Revision Cycle Yields Progress Amidst Obstinacy – AdvaMed
U.S. device industry reps expect Japanese "R-zone" price cuts to more closely approximate market conditions than foreign average pricing (FAP) revisions
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.